Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.
about
Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic SubstrateUse of MRI for Risk Stratification in Anticoagulation Decision Making in Atrial Fibrillation: Promising, but More Data are Needed for a Robust Algorithm.Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study.Predisposing factors for atrial fibrillation in the elderly.B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.Atrial Fibrillation and SCN5A Variants.The continuum of personalized cardiovascular medicine: a position paper of the European Society of CardiologyPrevalence of atrial fibrillation in patients with high CHADS2- and CHA2DS2VASc-scores: anticoagulate or monitor high-risk patients?Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis.Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations.The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysisThe ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study).Preserving Cognitive Function in Patients with Atrial FibrillationAtrial fibrillation: mechanisms, therapeutics, and future directions.Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases.The ECG as a tool to determine atrial fibrillation complexity.Prediction and personalised treatment of atrial fibrillation-stroke prevention: consolidated position paper of CVD professionals.Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study.Prevalence of atrial fibrillation and the HATCH score: Intensified monitoring of patients with high HATCH score.Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology.Does personalized medicine exist and can you test it in a clinical trial?The European Network for Translational Research in Atrial Fibrillation (EUTRAF): objectives and initial results.Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment.Atrial fibrosis: an obligatory component of arrhythmia mechanisms in atrial fibrillation?Current controversies in determining the main mechanisms of atrial fibrillation.The changing circumstance of atrial fibrillation - progress towards precision medicine.Influence of Inflammation and Atherosclerosis in Atrial Fibrillation.The burden of proof: The current state of atrial fibrillation prevention and treatment trials.[AFNET. A translational research network develops into an academic research organization].Prevalence and antithrombotic management of atrial fibrillation in hospitalised patients.An automated system using spatial oversampling for optical mapping in murine atria. Development and validation with monophasic and transmembrane action potentials.Altered atrial metabolism: an underappreciated contributor to the initiation and progression of atrial fibrillation.European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm SocieCalcium signalling silencing in atrial fibrillation.Coronary sinus signal amplitude predicts left atrial scarring.Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study.Health literacy, health-related quality of life, and atrial fbrillation.Anticoagulation after catheter ablation of atrial fibrillation guided by implantable cardiac monitors.Focal impulse and rotor modulation using the novel 64-electrode basket catheter: electrogram characteristics of human rotors.
P2860
Q26799163-25A1892E-0D5A-42BC-B5AC-B5C8ED14D3B6Q30745992-1129D26B-BDBF-4684-967D-A05181CDA97EQ31160340-1DADE9C2-50DD-4F3E-AED5-21F100D91B9CQ33766891-A19BC435-B7A9-41DD-B02B-8A509EA396EBQ34342621-FDCA3531-20E3-486F-AB15-16AD3677F674Q34626371-851DBE1C-FA06-4B0A-B5A5-7C42A3F3D768Q34644992-5E129953-1F6C-4479-813C-55D3922E45BCQ34805634-B0341A62-2C90-4D42-86D9-71BD1E214286Q36069585-71456EA4-F861-4D79-A163-91C0DDEB3168Q36188656-87835267-C03D-4B1C-9358-86106B3C8BFEQ36650575-05F48D04-9E67-49BD-8100-885FD2C7F48EQ36923167-D92A44B6-2CE0-493D-847B-544FEE8F49C9Q37007410-A16FA151-5F4D-41A4-B572-8C3985BF99B2Q37468856-4DC35E84-E5E2-4BC7-B907-4047EB5B84C7Q37590158-ADF9A714-FA79-4042-A78C-C6D7C5E64F2BQ37680793-6C6DCF0E-432F-4D03-88A0-91CAF7B42AD9Q38212528-0983C9F7-173A-4BD9-B0CA-7BD8139C779CQ38253047-9300F09F-2A58-492E-8A06-41F757A2BE7CQ38371641-E45744E7-A1BB-4BC7-B90E-372A1BF98B8FQ38413756-E4BE8847-12A4-483A-AC62-1F031CA0C7C6Q38528288-56954C77-1868-4B06-871E-E364B73A84AFQ38568617-5E956F73-F9E2-4608-9018-882FEC979471Q38585790-7CAA4095-FB6B-409C-AC8E-16775A070283Q38678441-412412A4-5DF0-4A18-B5F9-B237B26AC771Q38701353-FCFC2119-D20B-483D-823A-9EC6BE443326Q38780259-39D8D7F2-A665-4BB9-8D4D-F4B2D4DA42D5Q38793865-6026D37A-B7E2-4F7B-8587-1E0A66F442C5Q39094801-3CA91C0A-DB0F-4334-9114-295C5F1D0EB2Q39119910-66088B3F-D647-41A7-A3E8-BA0BBE8409AAQ40852337-897BD2FA-C1F8-4400-8CF3-010C59009FF0Q41075201-BE7E2254-C197-495F-9E7F-2CC9F1FDA27DQ41871786-AF95ED0D-A311-4F24-B227-4764F00A95B8Q43226639-D074B926-1781-43CC-8F08-700F8D5DF64AQ47796802-68816539-E23D-46D1-AFB9-E44437E96B02Q48089419-F8B52F17-D7B5-4902-9E25-6B032332B85AQ48354706-26B8FAFF-9037-4B79-A1AC-CCAB59A9BD13Q48710740-09471683-18E2-44BB-953D-73EE03345929Q49584575-723ACB3A-125D-47EE-B818-3D96C04D63A6Q50950530-C4EFE97D-2CA4-451C-9086-262F4CBD6830Q51668290-239783A4-DAE3-4234-B031-243DDCB63FEB
P2860
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Personalized management of atr ...... ociation consensus conference.
@ast
Personalized management of atr ...... ociation consensus conference.
@en
type
label
Personalized management of atr ...... ociation consensus conference.
@ast
Personalized management of atr ...... ociation consensus conference.
@en
prefLabel
Personalized management of atr ...... ociation consensus conference.
@ast
Personalized management of atr ...... ociation consensus conference.
@en
P2093
P2860
P50
P356
P1433
P1476
Personalized management of atr ...... ociation consensus conference.
@en
P2093
A John Camm
Alphons Vincent
Andrea Gerth
Andreas Clemens
Angelika Leute
Anne Gillis
Axel Brandes
Barbara Casadei
Berndt von Stritzky
P2860
P304
P356
10.1093/EUROPACE/EUT232
P50
P577
2013-08-27T00:00:00Z